ADMA Biologics is a biopharmaceutical company that develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases. The company's lead product candidate is Asceniv, a human immune globulin intravenous drug product that is used to treat primary humoral immunodeficiency. ADMA Biologics also offers Bivigam, a human immune globulin intravenous drug product that is used to treat primary humoral immunodeficiency, as well as other specialty plasma-derived biologics. The company was founded in 2004 and is headquartered in Ramsey, New Jersey.